Amit Chopra, Managing Director, India & South Asia, Thermo Fisher Scientific “The World Heart Day serves as an important reminder of the urgent need to prioritize heart health. India accounts for approximately 60% of the world's heart disease burden with a growing number of young adults
MedGenome Labs, a leading provider of genetic testing services in India, has announced the launch of a ground-breaking first-ever Facioscapulohumeral Muscular Dystrophy Type 1 (FSHD1) test in India. MedGenome Labs is the first commercial lab to offer this new genetic test that will help individuals
Join 2M+ industry professionals with MedgateToday - curated insights, delivered daily.
